Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on July 22, 2025
$717.3 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern Diagnostics | MarketsandMarkets™
GlobeNewswire
·
July 22, 2025
Delray Beach, FL, July 22, 2025 (GLOBE NEWSWIRE) -- What’s Fueling the Shift from Analog to AI-Powered Auscultation? The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance …
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
GlobeNewswire
·
July 22, 2025
BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life- …
Veru to Participate in the 2025 BTIG Virtual Biotech Conference
GlobeNewswire
·
July 22, 2025
MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …
InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- InStride Health, a leading insurance-based provider of specialty anxiety and obsessive-compulsive disorder (OCD) treatment for children, adolescents and young adults, today announced the appointment of Don LeBlanc …
LOBO EV (NASDAQ: LOBO) Unveils $3 Million Annual Revenue Opportunity with AI-Powered Senior Mobility Robot Launching October 2025
GlobeNewswire
·
July 22, 2025
WUXI, China, July 22, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ: LOBO) (“LOBO” or the “Company”), a leading manufacturer and innovator in electric mobility and intelligent systems, today announced a strategic partnership with the Jiangsu …
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
GlobeNewswire
·
July 22, 2025
THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into agreements …
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
GlobeNewswire
·
July 22, 2025
HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey as its new Vice President of Sales. A two-time U.S. …
SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients
GlobeNewswire
·
July 22, 2025
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance Registry which is assessing the use of the …
NKGen Biotech to Present at the Alzheimer’s Association International Conference 2025
GlobeNewswire
·
July 22, 2025
SANTA ANA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Full Alliance Group and Qubitera Holdings Launch Informational Website for YAHBEE – the First Three Tier Affiliate Cross Chain Wallet built for the GIG Economy
GlobeNewswire
·
July 22, 2025
TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), today announced that its majority-owned subsidiary, Qubitera Holdings, Inc., has officially launched www.yahbee.com, an informational website introducing …
Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 22, 2025
CORAL GABLES, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
GlobeNewswire
·
July 22, 2025
SYDNEY, July 22, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is …
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
GlobeNewswire
·
July 22, 2025
CARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡
GlobeNewswire
·
July 22, 2025
SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new results from its second …
AnswersNow Launches Corporate Advisory Board to Advance Scale of Innovative Virtual Autism Platform
GlobeNewswire
·
July 22, 2025
RICHMOND, Va., July 22, 2025 (GLOBE NEWSWIRE) -- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today introduced the founding members of its new Corporate Advisory Board. Kim Henrichsen, President of St. Louis University …
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
GlobeNewswire
·
July 22, 2025
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered …
aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
GlobeNewswire
·
July 22, 2025
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients
GlobeNewswire
·
July 22, 2025
FORT MYERS, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more …
Hydreight to Participate in the Canaccord Genuity 45th Annual Growth Conference in Boston
GlobeNewswire
·
July 22, 2025
VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) (“Hydreight” or the “Company”), a telehealth and mobile medical company operating across the U.S. focused on expanding access …
Survivor Healthcare Announces the Appointment of Catherine Cowan as Senior Vice President of Clinical Operations
GlobeNewswire
·
July 22, 2025
Cowan will oversee clinical strategy, quality improvement, and expansion of multidisciplinary care teams Appointment strengthens Survivor Healthcare’s mission to deliver integrated, high-quality primary care to cancer survivors with complex needs SALT LAKE …